Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

takeda pharma a/s - alogliptin benzoatas, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. trigubas derinys terapija), kaip papildoma priemonė kartu su dieta ir mankšta pagerinti glycaemic kontrolės pacientams, kai insulino per stabilią dozės ir metforminas vien nesuteikia pakankamos kontrolės glycaemic.